Results 121 to 130 of about 1,630,140 (194)

Prospective multi‐centre haemovigilance of amotosalen and ultraviolet A‐treated platelets and plasma in routine clinical use

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Amotosalen/ultraviolet A light (A/UVA) pathogen‐reduced platelets and plasma have been approved for clinical use in Europe since 2003 and 2006, respectively. Cross‐sectional safety haemovigilance (HV) studies have been conducted in 29 hospitals in 15 European countries since 2003. This report describes the most recent
Magdalena Łętowska, Anna Krukowska, Dariusz Piotrowski, Zofia Przybylska, Konrad Rosskopf, Angelo Ostuni, Margherita Giannoccaro, Rossella Procacci, Christine Ernst, Johannes Irsch, Laurence Corash, Richard J. Benjamin, Kathy Liu, Linh Dinh, John P. Pitman   +14 more
wiley   +1 more source

Apheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both?

, 2016
Babesiosis is a potentially life-threatening illness caused by intraerythrocytic protozoan parasites of the genus Babesia that are transmitted most commonly by Ixodes ticks, and rarely from blood transfusion or congenitally.
Krause, Peter J, Wu, Yanyun, Saifee, Nabiha Huq, Yanyun Wu, Nabiha Huq Saifee, Peter J. Krause   +5 more
core   +1 more source

From contamination to fever: The role of endotoxin levels in bacterially contaminated platelet concentrates

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Growth of gram‐negative bacteria in a platelet concentrate (PC) is inevitably accompanied by the accumulation of endotoxin, which is the major component of the outer cell membrane of these organisms. However, less is known about the kinetics of endotoxin accumulation in PC and its biological activity.
Marcel Prax, Lea Debes, Paul Adomeit, Michel‐Andrés García‐Otálora, Carl P. McDonald, Marc Cloutier, Ute Gravemann, Opeyemi Adesina, Morenike Adeoye‐Isijola, Josephine Hubloher, Hellen Sarela, Tanja Vollmer, Oleg Krut, Sandra Ramirez‐Arcos, ISBT Transfusion‐Transmitted Infectious Diseases Working Party “Subgroup on Bacteria”   +14 more
wiley   +1 more source

Management of Pregnancy in a Patient with Familial Hypercholesterolemia and Previous Myocardial Infarction—Treatment with LDL Apheresis: A Case Report

Reports
Familial hypercholesterolemia, a genetic disorder marked by elevated low-density lipoprotein cholesterol (LDL-C), poses significant risks for premature atherosclerosis and cardiovascular diseases, particularly during pregnancy. One of the safe methods of
Milos Milincic, Jovana Todorovic, Stefan Dugalic, Ivana Novakovic, Maja Macura, Katarina Lalic, Miroslava Gojnic Dugalic   +6 more
doaj   +1 more source

Calcineurin Inhibitor–Free, mTOR‐Based Immunosuppression in Chimeric Antigen Receptor T‐Cell Therapy for Post‐Transplant Lymphoproliferative Disorder

eJHaem, Volume 7, Issue 6, December 2026.
ABSTRACT Introduction Relapsed/refractory post‐transplant lymphoproliferative disorder (PTLD) remains a challenging complication after solid organ transplantation (SOT), requiring complex balancing of immune‐suppressive therapy (IST) and lymphoma‐directed therapies. Methods We report the case of a 40‐year‐old female kidney‐pancreas transplant recipient
Maria Mappoura, Yara Hajj Younes, Sisi Wang, Kadiatou Baldet, Carmen De Ramon Ortiz, Sarah Morin, Stavroula Marouridi‐Levrat, Amandine Pradier, Astrid Melotti, Pragallabh Purwar, Chiara Bernardi, Liza Ho, Kristof Egervari, Julie Ducreux, Thomas Longval, Francesco Bertoni, Yves Chalandon, Fadi Haidar, Sophie de Seigneux, Jean Villard, Valérie Olivier, Federico Simonetta   +21 more
wiley   +1 more source

Intermittent immunoadsorption in critically ill patients with neuroimmunological disorders: a retrospective study

Frontiers in Neurology
ObjectivesThis study aimed to evaluate the efficacy and safety of intermittent immunoadsorption (IA) in critically ill patients with refractory autoimmune neurological disorders.MethodsWe retrospectively reviewed 13 patients admitted to the neurocritical
Qian Wu, Lin Zhu, Lin Zhu, Shujuan Dai, Jing Xu, Deshan Ge   +5 more
doaj   +1 more source

Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis. [PDF]

Mol Psychiatry, 2023
Achleitner M, Steenblock C, Dänhardt J, Jarzebska N, Kardashi R, Kanczkowski W, Straube R, Rodionov RN, Bornstein N, Tselmin S, Kaiser F, Bucher R, Barbir M, Wong ML, Voit-Bak K, Licinio J, Bornstein SR.   +16 more
europepmc   +1 more source

When blood is needed but not available: A proposal for measuring patient‐level blood unavailability

Transfusion, EarlyView.
Shreenik Kundu, Ayla Gerk, Meghan Delaney, Dan Poenaru   +3 more
wiley   +1 more source

Clinical Impact of CTLA4 and LAG3 Single‐Nucleotide Polymorphisms in Multiple Myeloma Patients Treated With BCMA CAR T‐Cell Therapy

Hematological Oncology, Volume 44, Issue 6, November 2026.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy targeting B‐cell maturation antigen (BCMA) is a highly effective treatment option for patients with relapsed refractory multiple myeloma (RRMM). However, reliable biomarkers predicting long‐term treatment response remain elusive. Germline single‐nucleotide polymorphisms (SNPs) in immune checkpoint
Elisa Suter, Martina Bertschinger, Inna Shaforostova, Marie‐Noelle Kronig, Henning Nilius, Ulrike Bacher, Katja Seipel, Thomas Pabst   +7 more
wiley   +1 more source

Proposal of the Need for New Korean Guidelines on the Use of Therapeutic Apheresis in Clinical Practice. [PDF]

Ann Lab Med, 2022
Chung Y, Kim H, Ko DH.
europepmc   +1 more source